Independent fund research. Built on SEC filings.

How we research funds

ETF · Health Care Sector · ARK Invest

ARKG Holdings: What ARK Genomic Revolution ETF Owns

Ticker ARKG · · Holdings as of Jul 31, 2026

Expense ratio
0.75%$75/yr per $10k
5-yr return
−6.5%annualized
1-yr return
−28.1%as of Dec 2024
Net assets
$1.6Ball share classes
Holdings
33

Bottom line

What does ARKG hold?

ARKG held 33 positions as of Jul 31, 2026. Its largest holding is 10x Genomics Inc at 9.39% of the fund, and the top 10 positions add up to 59.1%. By asset type it is 100% stocks, 0% cash & short-term funds.

Updated Sep 22, 2026

ARKG top 25 holdings

#HoldingType% of fundValue
1 10x Genomics Inc TXG
10X GENOMICS INC CL A COM
Stocks 9.39%$146.3M
2 Twist Bioscience Corp TWST
TWIST BIOSCIENCE CORP COM
Stocks 7.73%$120.4M
3 Tempus Ai Inc TEM
TEMPUS AI INC CL A
Stocks 6.56%$102.2M
4 Crispr Therapeutics Ag CRSP
CRISPR THERAPEUTICS AG NAMEN AKT
Stocks 6.29%$97.9M
5 Personalis Inc PSNL
PERSONALIS INC COM
Stocks 5.47%$85.3M
6 Absci Corp ABSI
ABSCI CORP COM
Stocks 5.14%$80.0M
7 Guardant Health Inc GH
GUARDANT HEALTH INC COM
Stocks 4.74%$73.8M
8 Illumina Inc ILMN
ILLUMINA INC COM
Stocks 4.74%$73.8M
9 Eli Lilly & Company LLY
ELI LILLY & COMPANY COM
Stocks 4.68%$73.0M
10 Caredx Inc CDNA
CAREDX INC COM
Stocks 4.30%$66.9M
11 Natera Inc NTRA
NATERA INC COM
Stocks 4.13%$64.3M
12 Beam Therapeutics Inc BEAM
BEAM THERAPEUTICS INC COM
Stocks 3.78%$58.8M
13 Compass Pathways Plc CMPS
COMPASS PATHWAYS PLC SPONSORED ADS
Stocks 3.25%$50.7M
14 Recursion Pharmaceuticals Inc RXRX
RECURSION PHARMACEUTICALS INC CL A
Stocks 2.63%$40.9M
15 Adaptive Biotechnologies Corp ADPT
ADAPTIVE BIOTECHNOLOGIES CORP COM
Stocks 2.57%$40.1M
16 Veracyte Inc VCYT
VERACYTE INC COM
Stocks 2.55%$39.7M
17 Nurix Therapeutics Inc NRIX
NURIX THERAPEUTICS INC COM
Stocks 2.51%$39.0M
18 Butterfly Network Inc BFLY
BUTTERFLY NETWORK INC COM CL A
Stocks 2.18%$33.9M
19 Schrodinger Inc SDGR
SCHRODINGER INC COM
Stocks 1.99%$30.9M
20 Genedx Holdings Corp WGS
GENEDX HOLDINGS CORP COM CL A
Stocks 1.87%$29.1M
21 Intellia Therapeutics Inc NTLA
INTELLIA THERAPEUTICS INC COM
Stocks 1.83%$28.5M
22 Ionis Pharmaceuticals Inc IONS
IONIS PHARMACEUTICALS INC COM
Stocks 1.77%$27.5M
23 Alamar Biosciences Inc ALMR
ALAMAR BIOSCIENCES INC COMMON STOCK
Stocks 1.56%$24.3M
24 Prime Medicine Inc PRME
PRIME MEDICINE INC COM
Stocks 1.41%$21.9M
25 Generate Biomedicines Inc GENB
GENERATE BIOMEDICINES INC COM SHS
Stocks 1.11%$17.3M

Source: SEC Form N-PORT, period ended Jul 31, 2026, filed Sep 22, 2026

Asset mix

Stocks99.6%
Cash & short-term funds0.2%

Country exposure

CH6.3%
GB3.3%
US90.3%